Comparative effects of weight loss and incretin-based therapies on vascular endothelial function, fibrinolysis and inflammation in individuals with obesity and prediabetes: A randomized controlled trial
The heart rate increase is a pharmacological effect, not a pathological one
for example, Lilly expects to share Phase 3 obesity data on orfoglipron, an oral GLP-1 agonist, and retatrutide, a triple agonist of GLP/GIP/glucagon receptors in 2025 3 Xie, Y., Choi, T., & Al-Aly, Z
Is Tylenol a better option than aspirin for pain while on tirzepatide
Where necessary, topical treatment with preservative-free artificial tears and antibiotics can be given if bacterial infection is present (Feroze and Kaufman, 2023)
Beyond genetics, consistency matters enormously